126 related articles for article (PubMed ID: 2764640)
1. Idebenone improves learning and memory impairment induced by cholinergic or serotonergic dysfunction in rats.
Yamazaki N; Nomura M; Nagaoka A; Nagawa Y
Arch Gerontol Geriatr; 1989 May; 8(3):225-39. PubMed ID: 2764640
[TBL] [Abstract][Full Text] [Related]
2. [Effect of idebenone on scopolamine-induced impairment of short-term memory in rats].
Yamazaki N; Nagaoka A; Nagawa Y
Yakubutsu Seishin Kodo; 1985 Dec; 5(4):321-8. PubMed ID: 3832686
[TBL] [Abstract][Full Text] [Related]
3. [Effect of idebenone (CV-2619) on brightness discrimination learning in rats with central serotonergic dysfunction].
Nomura M
Yakubutsu Seishin Kodo; 1985 Sep; 5(3):243-9. PubMed ID: 4072435
[TBL] [Abstract][Full Text] [Related]
4. Effects of idebenone on memory impairment induced in ischemic and embolization models of cerebrovascular disturbance in rats.
Yamazaki N; Kiyota Y; Take Y; Miyamoto M; Nagawa Y; Nagaoka A
Arch Gerontol Geriatr; 1989 May; 8(3):213-24. PubMed ID: 2764639
[TBL] [Abstract][Full Text] [Related]
5. [Ameliorating effects of idebenone and indeloxazine hydrochloride on impairment of radial maze learning in cerebral embolized rats].
Kiyota Y; Miyamoto M; Nagaoka A
Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):197-202. PubMed ID: 2731809
[TBL] [Abstract][Full Text] [Related]
6. Effect of idebenone (CV-2619) on memory impairment observed in passive avoidance task in rats with cerebral embolization.
Kiyota Y; Hamajo K; Miyamoto M; Nagaoka A
Jpn J Pharmacol; 1985 Mar; 37(3):300-2. PubMed ID: 3999479
[TBL] [Abstract][Full Text] [Related]
7. [Effect of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on scopolamine-induced impairment of short-term memory in rats].
Yamazaki N; Nagaoka A; Nagawa Y
Yakubutsu Seishin Kodo; 1986 Sep; 6(3):359-66. PubMed ID: 3101313
[TBL] [Abstract][Full Text] [Related]
8. Involvement of cholinergic and GABAergic systems in the reversal of memory disruption by NS-105, a cognition enhancer.
Ogasawara T; Itoh Y; Tamura M; Mushiroi T; Ukai Y; Kise M; Kimura K
Pharmacol Biochem Behav; 1999 Sep; 64(1):41-52. PubMed ID: 10494996
[TBL] [Abstract][Full Text] [Related]
9. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats.
Hiramatsu M; Murasawa H; Nabeshima T; Kameyama T
J Pharmacol Exp Ther; 1998 Mar; 284(3):858-67. PubMed ID: 9495843
[TBL] [Abstract][Full Text] [Related]
10. Minaprine improves impairment of working memory induced by scopolamine and cerebral ischemia in rats.
Yamamoto T; Yatsugi S; Ohno M; Furuya Y; Kitajima I; Ueki S
Psychopharmacology (Berl); 1990; 100(3):316-22. PubMed ID: 2315427
[TBL] [Abstract][Full Text] [Related]
11. Effects of thymoquinone on scopolamine-induced spatial and echoic memory changes through regulation of lipid peroxidation and cholinergic impairment.
Kantar D; Acun AD; Danışman B
Behav Brain Res; 2022 Aug; 431():113972. PubMed ID: 35718231
[TBL] [Abstract][Full Text] [Related]
12. Anti-amnesic effect of extract and alkaloid fraction from aerial parts of Peganum harmala on scopolamine-induced memory deficits in mice.
Liu W; Zhu Y; Wang Y; Qi S; Wang Y; Ma C; Li S; Jiang B; Cheng X; Wang Z; Xuan Z; Wang C
J Ethnopharmacol; 2017 May; 204():95-106. PubMed ID: 28442406
[TBL] [Abstract][Full Text] [Related]
13. The selective 5-HT6 receptor antagonist Ro4368554 restores memory performance in cholinergic and serotonergic models of memory deficiency in the rat.
Lieben CK; Blokland A; Sik A; Sung E; van Nieuwenhuizen P; Schreiber R
Neuropsychopharmacology; 2005 Dec; 30(12):2169-79. PubMed ID: 15957009
[TBL] [Abstract][Full Text] [Related]
14. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice.
Hiramatsu M; Inoue K
Br J Pharmacol; 1999 Jun; 127(3):655-60. PubMed ID: 10401555
[TBL] [Abstract][Full Text] [Related]
15. Physostigmine, but not 3,4-diaminopyridine, improves radial maze performance in memory-impaired rats.
Beninger RJ; Wirsching BA; Mallet PE; Jhamandas K; Boegman RJ
Pharmacol Biochem Behav; 1995 Aug; 51(4):739-46. PubMed ID: 7675853
[TBL] [Abstract][Full Text] [Related]
16. SLV330, a cannabinoid CB1 receptor antagonist, ameliorates deficits in the T-maze, object recognition and Social Recognition Tasks in rodents.
de Bruin NM; Prickaerts J; Lange JH; Akkerman S; Andriambeloson E; de Haan M; Wijnen J; van Drimmelen M; Hissink E; Heijink L; Kruse CG
Neurobiol Learn Mem; 2010 May; 93(4):522-31. PubMed ID: 20132903
[TBL] [Abstract][Full Text] [Related]
17. The role of the dorsal raphe-serotonergic system and cholinergic receptors in the modulation of working memory.
Ruotsalainen S; Miettinen R; MacDonald E; Riekkinen M; Sirviö J
Neurosci Biobehav Rev; 1998; 22(1):21-31. PubMed ID: 9491938
[TBL] [Abstract][Full Text] [Related]
18. Effect of cholinergic activation by physostigmine on working memory failure caused in rats by pharmacological manipulation of hippocampal glutamatergic and 5-HTergic neurotransmission.
Ohno M; Kishi A; Watanabe S
Neurosci Lett; 1996 Oct; 217(1):21-4. PubMed ID: 8905730
[TBL] [Abstract][Full Text] [Related]
19. Endomorphin-1 improves scopolamine-induced impairment of short-term memory via mu1-opioid receptor in mice.
Ukai M; Katoh T; Mamiya T
Neuroreport; 2001 Dec; 12(17):3723-7. PubMed ID: 11726782
[TBL] [Abstract][Full Text] [Related]
20. Effects of cholinergic drugs and cerebral metabolic activators on memory impairment in old rats.
Kamei C; Tsujimoto S; Tasaka K
J Pharmacobiodyn; 1990 Dec; 13(12):772-7. PubMed ID: 2098550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]